MENU

Tricor

Tricor

 

 




































Unfavorable events reported by 2 % or even more of individuals treated regarding fenofibrate(and also above placebo )during the double-blind, placebo-controlled tests, despite causality, are noted in Table 1 here. Damaging events resulted in discontinuation of therapy in 5.0 % of patients treated regarding fenofibrate and in 3.0 % treated with sugar pill. Boosts in liver function tests were the most constant events, creating discontinuation of fenofibrate therapy in 1.6 % of people in double-blind tests. Table 1. Negative Reactions Reported by 2 % or More of Patients Treated regarding Fenofibrate as well as Greater compared to Placebo During the Double-Blind, Placebo-Controlled Trials. The following unfavorable responses have been identified throughout postapproval use of fenofibrate: myalgia, rhabdomyolysis, pancreatitis, acute renal failing, muscle contraction, liver disease, cirrhosis, anemia, arthralgia, decreases in hemoglobin, reduces in hematocrit, white blood cell reductions, asthenia, and significantly disheartened HDL-cholesterol levels. Because these reactions are reported willingly from

a populace of unpredictable dimension, it is not constantly possible to accurately estimate their regularity or set up a causal connection to medication direct exposure. When coumarin anticoagulants are given in combination with Tricor, caution should be worked out. The dose of the anticoagulants should be decreased to preserve the PT/INR at the desired degree to stop bleeding problems. Regular PT/INR decisions are recommended until it has actually been absolutely determined that the PT/INR has stabilized [see Warnings as well as Precautions(5.

All rights reserved (c) 2011